Pulmonary Arterial Hypertension

The AJMC® Pulmonary Arterial Hypertension compendium is a comprehensive resource for clinical news and expert insights for the progressive disorder, which is characterized by high blood pressure in the arteries that go from the heart to the lungs.

How Much Do Physicians Know About SDOH in Their Patients With PAH?

July 28th 2022, 4:42pm


Clinicians interviewed in a recent study reported various social determinants of health (SDOH) affecting health outcomes for patients with pulmonary arterial hypertension (PAH), indicating the need to address SDOH in PAH care.

HFpEF-PH Improves Following Treatment With Sacubitril/Valsartan

July 19th 2022, 11:00pm


Several measures of hemodynamic capacity were improved in this study that evaluated sacubitril/valsartan use for heart failure with preserved ejection fraction and pulmonary hypertension (HFpEF-PH).

Functional Capacity Dropped Among Patients With PAH Following COVID-19 Lockdown

July 12th 2022, 7:43pm


A Belgian study compared exercise performance before and after COVID-19 lockdown measures were swiftly implemented in the country among patients with preexisting pulmonary arterial hypertension (PAH).

New Findings May Have Implications for PH Classification

July 8th 2022, 1:57pm


Researchers have found that patients who have idiopathic pulmonary arterial hypertension (IPAH) with a phenotype characterized by a smoking history and low diffusion capacity for carbon monoxide had little in common with patients with classical IPAH.

Monotherapy May Be Preferred Over Combination Therapy for Specific Patients With PAH

June 29th 2022, 4:22pm


Despite current guidelines recommending combination therapy, there are certain patients with pulmonary arterial hypertension (PAH) who remain on monotherapy for specific reasons.

Study Highlights Need for Validated Blood Biomarkers in PAH

June 23rd 2022, 4:04pm


Collecting more than 3 decades’ worth of data, researchers determined that none of the identified blood biomarkers are accurate enough to take the place of current diagnostic approaches, either due to lack of data or lack of specificity.

Dr Gary Owens Discusses Patient-Centered Care in PAH

June 5th 2022, 4:49pm


Gary Owens, MD, president of Gary Owens Associates, explains the importance of shared decision making and patient-centered care in pulmonary arterial hypertension (PAH).

Intestinal Microbiota May Potentially Serve as Therapeutic Target in PAH

June 4th 2022, 12:58am


Dr Gary Owens Describes Treatments in the Pipeline for PAH

May 25th 2022, 6:42pm


Gary Owens, MD, president of Gary Owens Associates, describes mechanisms, trials of treatments in the works for pulmonary arterial hypertension (PAH).

Researchers Highlight Risks of RHC in Pediatric Patients With PAH

May 16th 2022, 6:46pm


Based on their findings, the researchers of the retrospective study are calling for close evaluation, careful monitoring, and appropriate treatment to mitigate complications and mortality.